UNSPSC 85893010: High dose rate (hdr) brachytherapy of pancreas using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of pancreas using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DF1399Z

UNSPSC 85893010 High dose rate (HDR) brachytherapy of pancreas using iodine 125 (I-125) is a Commodity code whose nominal scope—specialized oncology radiation therapy—does not align with recent state and local procurement activity under this code. The only identified recent opportunity is a County of Santa Clara Health System RFQ for temporary health professional staffing services across ancillary clinical categories including audiology, diagnostic imaging, respiratory care, and surgical/operating room support, due October 7, 2026. This staffing solicitation falls outside the code's specialized brachytherapy domain and suggests either a classification mismatch in the state and local posting or minimal relevant procurement activity under the code's intended scope.

The code shows no recent opportunities for brachytherapy equipment, radiation oncology services, or the specialized technical and clinical infrastructure required to deliver pancreatic cancer treatment via iodine-125 implantation. Without additional opportunities in the source data, the code does not present a clear market signal for brachytherapy vendors pursuing state or local health system contracts at this time. Firms in this specialty should monitor for direct RFPs from comprehensive cancer centers and academic medical centers, which are the primary institutional buyers of such equipment and services, but should not expect significant activity under this commodity code designation.